secwatch.observer — SEC 8-K summary
======================================

Issuer:     Dermata Therapeutics, Inc. (DRMA)
CIK:        0001853816
Form:       8-K
Filed at:   2023-05-24T23:59:59+00:00
Accession:  0001654954-23-007177
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 3.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Dermata Therapeutics raises ~$1.8M via registered direct offering and private placement
--------------------------------------------------------------------------------

- Sold 800,877 shares (or common stock equivalents) at $2.285 per share, gross proceeds ~$1.8M.
- Issued warrants to purchase up to 800,877 shares at $2.16/share, exercisable immediately, 5.5-year term.
- Placement agent H.C. Wainwright will receive 7% cash fee and warrants for 56,061 shares at $2.8563/share.
- Closing expected on or about May 26, 2023, subject to customary conditions.
- Proceeds to be used for general corporate purposes including R&D, clinical trials, and working capital.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1853816/000165495423007177/0001654954-23-007177-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1853816/000165495423007177/drma_8k.htm
  HTML page:      https://secwatch.observer/filing/0001654954-23-007177

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer